Allergy, Immunology, and ENT

Latest News

Weight-tiered higher doses of dupilumab improves key disease measures of EoE | Image Credit: © Yurii Kibalnik - © Yurii Kibalnik - stock.adobe.com.
Weight-tiered higher doses of dupilumab improves key disease measures of EoE

June 27th 2024

New data for FDA-approved dupilumab (Dupixent; Regeneron and Sanofi) highlights positive study results for the eosinophilic esophagitis (EoE) treatment in children aged 1 to 11 years.

Image Credit: © Artur - © Artur - stock.adobe.com.
Weekly review: ADHD treatment FDA approval, peanut consumption and adolescent tolerance, and more

June 3rd 2024

Belimumab autoinjector approved for systemic lupus erythematosus patients 5 years and older | Image Credit: © Calin - © Calin - stock.adobe.com.
Belimumab autoinjector approved for systemic lupus erythematosus patients 5 years and older

May 31st 2024

Peanut consumption through 5 years of age provides lasting tolerance into adolescence | Image Credit: © Tanawut - © Tanawut - stock.adobe.com.
Peanut consumption through 5 years of age provides lasting tolerance into adolescence

May 29th 2024

FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years

May 13th 2024

More News


Site Logo

Wheeze in Preschool Children:

April 1st 2007

Severe disability and even death can result from the inappropriate diagnosis and treatment of a young child's wheezing, which is heterogeneous in its origins and expression. Consequently, a differential diagnosis is necessary to determine the cause and to develop an effective management strategy. Viral-induced wheeze, especially from respiratory syncytial virus (RSV), manifests as a bronchiolitis. Recent reports show that the cysteinyl leukotrienes are an important mediator of the airway effects of RSV infection and that leukotriene receptor antagonists reduce postrespiratory syncytial virus lung symptoms. Exercise-induced bronchoconstriction manifests as wheezing and can be treated or pretreated short-term with inhaled bronchodilators or cromolyn: long-term therapy includes inhaled corticosteroids and leukotriene receptor antagonists. Allergic rhinitis-associated wheeze may be the result of acute exposure to an allergen or simply from nasal dysfunction. Control of allergic rhinitis with intranasal steroids, antihistamines, or leukotriene receptor antagonists could relieve the wheezing. Asthma-associated wheeze requires long-term use of 1 or more daily controller medications. The primary goal is to navigate the child safely through the first episode of wheezing, consider the causes of the wheeze, and then evaluate the need for further therapy. All apparent causes of wheeze should be treated with the idea that if the apparent cause turns out not to be the actual cause, treatment can be safely discontinued.

© 2024 MJH Life Sciences

All rights reserved.